Emily E. Bosco

1.6k citations
21 papers · 1.1k indexed · h-index 12

Impact in

  • Oncology top 5%
    • Cancer-related Molecular Pathways
    • Cancer Cells and Metastasis
    • Microtubule and mitosis dynamics

Papers in

    • Cancer-related Molecular Pathways 8
    • CAR-T cell therapy research 2
    • Microtubule and mitosis dynamics 2

Emily E. Bosco

19 papers receiving 1.0k citations

Peers

Emily E. Bosco
Comparison fields: 5 of 81
  • Oncology 463
  • Cell Biology 229
  • Cancer Research 207
  • Molecular Biology 654
  • Ophthalmology 74
Replace Toshifumi Yae with:
Toshifumi Yae Japan
Verline Justilien United States
Claudio Raimondi United Kingdom
Seung I. Ha United States
Zaher Nahlé United States
María Sol Degese Argentina
Hiroyuki Imaki Japan
Hui-Kuan Lin United States
Dawid G. Nowak United States
Kimberley J. E. Sweeney Australia
Emily E. Bosco relative to Toshifumi Yae Japan Toshifumi Yae's profile →
Citations per field
00.5×2.6×
Toshifumi Yae · 1×
Citations per year

Countries citing papers authored by Emily E. Bosco

Since Specialization
Citations

This map shows the geographic impact of Emily E. Bosco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Bosco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Bosco more than expected).

Fields of papers citing papers by Emily E. Bosco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily E. Bosco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Bosco. The network helps show where Emily E. Bosco may publish in the future.

Co-authors

The 25 scholars most cited alongside Emily E. Bosco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emily E. Bosco Line = papers co-authored together Emily E. Bosco links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20213
4 201631
5 20152
6 201249
7 201048
8 201022
9
Visions and Reflections (Minireview) Rac1 GTPase: A "Rac" of All Trades
20091
10 2008285
11 2008126
12 200766
13 200787
14 20063
15 2006150
16 200518
17 200577
18 20047
19 200480
20
Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
19937

About Emily E. Bosco

Emily E. Bosco is a scholar working on Oncology, Cell Biology, Molecular Biology, Ophthalmology and Microbiology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (4 papers), Cancer therapeutics and mechanisms (3 papers), Glycosylation and Glycoproteins Research (2 papers), CAR-T cell therapy research (2 papers), TGF-β signaling in diseases (2 papers), Microtubule and mitosis dynamics (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Oncology (463 citations), Cell Biology (229 citations), Cancer Research (207 citations), Molecular Biology (654 citations) and Ophthalmology (74 citations). Emily E. Bosco has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Yi Zheng, James C. Mulloy, Erik S. Knudsen, Huan Xu, Bruce J. Aronow, Scott W. Lowe, Ying Wang, Karen E. Knudsen, Jack T. Zilfou and Christopher N. Mayhew. Their work appears in journals such as Cancer Research, Oncogene, Nucleic Acids Research, Cancer Biology & Therapy and Cell Cycle.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026